VGX Pharmaceuticals

Latest Headlines

Latest Headlines

Inovio, VGX ink hep B and C vaccine deal

Blue Bell, PA-based Inovio Pharmaceuticals and VGX International will collaborate on the development of Inovio's synthetic vaccines for hepatitis B and hepatitis C. Financial details of the deal were

VGX Pharma gets $23M NIH grant for HIV vax

Start-up VGX Pharmaceuticals has been awarded $23 million from the National Institutes of Health to complete the development and manufacturing of their preventive HIV vaccine, which is now in the

Inovio merging with VGX to work on DNA vaccines

DNA vaccine delivery company Inovio Biomedical is merging with DNA vaccine developer VGX Pharmaceuticals. Inovio is issuing new shares for the deal, which should close before the end of the year. The